Novel therapy in multiple myeloma

Treatment in patients with multiple myeloma remain to be defined. Younger patients (defined as a cut-off level < 65 years old) will be treated with chemotherapy and transplant procedures. However, most patients > 65 years old are not candidates for this therapeutic approach and the use of inte...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Investigational new drugs 2005-10, Vol.23 (5), p.411-415
Hauptverfasser:	Avilés, Agustin, Neri, Natividad, Nambo, M Jesús, Cleto, Sergio, Castañeda, Claudia, González, Martha, Talavera, Alejandra, Huerta-Guzmán, Judith
Format:	Artikel
Sprache:	eng
Schlagworte:	Acids Aged Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Blood pressure Bone marrow Chemotherapy Dexamethasone - administration & dosage Dexamethasone - adverse effects Disease-Free Survival Drug dosages Female Humans Immunosuppressive Agents - administration & dosage Immunosuppressive Agents - adverse effects Interferon Interferon-alpha - administration & dosage Interferon-alpha - adverse effects Laboratories Male Medical prognosis Multiple myeloma Multiple Myeloma - drug therapy Multiple Myeloma - radiotherapy Oncology Proteins Recombinant Proteins Remission (Medicine) Response rates Stem cells Thalidomide - administration & dosage Thalidomide - adverse effects Toxicity Transplants & implants Tretinoin - administration & dosage Tretinoin - adverse effects Urine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!